Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3176 |
|
Actual shortage: | 259 (8%) | |
Anticipated shortage: | 5 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2903 (91%) | |
Discontinuation Reports |
355 |
|
To be discontinued: | 22 (6%) | |
Discontinued: | 333 (94%) | |
Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
33 (12%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-RISEDRONATE | 35MG | TABLET | Resolved | 2018-10-19 | 2018-12-21 | 64981 |
APO-CANDESARTAN | 32MG | TABLET | Resolved | 2017-03-20 | 2020-02-25 | 3516 |
APO-CANDESARTAN | 32MG | TABLET | Resolved | 2020-05-13 | 2020-09-21 | 114928 |
APO-CANDESARTAN | 32MG | TABLET | Actual shortage | 2021-10-22 | 2021-10-22 | 147815 |
APO-CANDESARTAN | 32MG | TABLET | Actual shortage | 2022-03-11 | 2022-03-11 | 156534 |
APO ASA TAB 325MG | 325MG | TABLET | Actual shortage | 2017-08-13 | 2017-10-05 | 18948 |
APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2017-12-05 | 2018-07-03 | 31812 |
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Resolved | 2019-04-10 | 2019-04-12 | 80923 |
APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2019-09-12 | 2019-10-18 | 93665 |
ACETAMINOPHEN CAPLETS 325 MG | 325MG | TABLET | Resolved | 2020-04-01 | 2020-06-02 | 110297 |
ACETAMINOPHEN TABLETS USP 325 MG | 325MG | TABLET | Resolved | 2020-04-01 | 2020-05-25 | 110329 |
APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2021-09-24 | 2021-09-28 | 146151 |
APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-04-08 | 2022-05-13 | 158336 |
APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-05-13 | 2022-07-11 | 160601 |
APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-05-27 | 2022-07-11 | 161436 |
APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-08-09 | 2022-10-20 | 166399 |
APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-08-26 | 2022-09-23 | 168041 |
APO-ACETAMINOPHEN | 325MG | TABLET | Resolved | 2022-09-23 | 2022-10-21 | 170106 |
APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-10-07 | 2022-10-21 | 171417 |
APO-ACETAMINOPHEN CAPLETS | 325MG | TABLET | Resolved | 2022-12-05 | 2023-01-06 | 177111 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 | ||
ACID CONTROL | Discontinued | 2019-01-04 | 2019-01-04 | 71198 | ||
APO-RIZATRIPTAN RPD | Discontinued | 2019-01-04 | 2019-04-04 | 71334 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78141 | ||
APO PEN VK | Discontinued | 2019-03-08 | 2019-03-08 | 78144 |